Could a simple breath test catch pancreatic cancer sooner?

NCT ID NCT07243262

First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study is testing a non-invasive breath test to detect pancreatic cancer earlier. Researchers will collect breath samples from over 6,000 people who have been referred for possible pancreatic cancer. The goal is to see if the test can accurately identify the small number of people who actually have the disease, helping doctors decide who needs further testing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
breath test
What this could lead to
If successful, this breath test could help doctors spot pancreatic cancer earlier, when more treatment options are available and survival chances are better.
What could go wrong
This is a validation study, not a treatment trial. The test may not be accurate enough in real-world use, and false positives or negatives could occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Imperial College Healthcare NHS Trust

    RECRUITING

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.